PALLIATIVE RADIOTHERAPY FOR BONE PAIN IN HORMONE REFRACTORY PROSTATE CANCER
نویسندگان
چکیده
منابع مشابه
[Palliative radiotherapy for local progression of hormone refractory stage D2 prostate cancer].
From 1970 to 1992, 10 patients with hormone refractory stage D2 adenocarcinoma of the prostate presenting themselves with urinary retention and/or gross hematuria were treated by palliative irradiation for local progression at Cancer Institute Hospital. External beam irradiation was delivered to the primary lesion at dose of 38 Gy to one patient and 30 approximately 27 Gy to seven patients. Fiv...
متن کاملPalliative radiotherapy for prostate cancer.
Radiotherapy is an effective tool for the palliation of symptoms commonly caused by prostate cancer. The majority of painful bone metastases respond equally well to single or multiple fractions of external radiotherapy. Retreatment with a second course of radiation induces pain responses in approximately 50% of patients. For more diffuse metastases, either hemibody radiation or systemic radioph...
متن کاملPalliative radiotherapy for prostate cancer: encouraging single-fraction radiotherapy.
Palliative radiotherapy is an effective treatment for the management of symptoms from advanced and metastatic prostate cancer, particularly for relief of pain from bone metastases. In their review, Drs. Boyer, Salama, and Lee concisely examine the data for external beam radiation therapy for uncomplicated bone metastases and cord compression in men with prostate cancer metastatic to bone.[1] Th...
متن کاملPrognostic indicators in hormone refractory prostate cancer.
Prognostic factors in hormone refractory prostate cancer currently are of limited use to clinicians. Although studies have identified several factors that predict for poor survival in patients, most are either retrospective, or nonrandomized. Therefore, large prospective, randomized trials are needed to validate the significance of these factors. In addition, these indicators are largely descri...
متن کاملCancer and bone repair mechanism: clinical applications for hormone refractory prostate cancer.
It is a long-standing clinical observation that the bone corresponds to the prevalent site for metastatic growth of prostate cancer. In addition, bone metastases of this malignancy produce a potent blastic reaction, in contrast to the overwhelming majority of other osteotropic neoplasms, whose metastases are generally associated with an osteolytic reaction. Osteoblastic metastases represent alm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Japanese Journal of Urology
سال: 1993
ISSN: 0021-5287,1884-7110
DOI: 10.5980/jpnjurol1989.84.1791